82_FR_11267 82 FR 11234 - Center for Scientific Review; Notice of Closed Meetings

82 FR 11234 - Center for Scientific Review; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 33 (February 21, 2017)

Page Range11234-11235
FR Document2017-03281

Federal Register, Volume 82 Issue 33 (Tuesday, February 21, 2017) 
[Federal Register Volume 82, Number 33 (Tuesday, February 21, 2017)]
[Notices]
[Pages 11234-11235]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-03281]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Fellowships: Genes, Genomes, and Genetics.
    Date: March 6-7, 2017.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Marriott Chevy Chase, 5520 Wisconsin Ave., Chevy Chase, 
MD 20815.
    Contact Person: Tatiana V. Cohen, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5213, Bethesda, MD 20892, 301-
455-2364, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR-16-209: Investigator-Initiated Clinical Sequencing 
Research.
    Date: March 13, 2017.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892.
    Contact Person: Peter J. Kozel, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3139, Bethesda, MD 20892, 301-
435-1116, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Psychopathology, Developmental Disorders, 
Epigenetics, and Health.
    Date: March 14-15, 2017.
    Time: 10:00 a.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Wind Cowles, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3172, Bethesda, MD 20892, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: AIDS and Related Research.
    Date: March 15, 2017.
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Dimitrios Nikolaos Vatakis, Ph.D., Scientific 
Review Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3190, Bethesda, MD 20892, 301-
827-7480.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR Panel: Advanced Genomic Technology Development.
    Date: March 15, 2017.
    Time: 11:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Dominique Lorang-Leins, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5108, MSC 7766, Bethesda, MD 
20892, 301.326.9721, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR-16-329: Countermeasures Against Chemical Threats 
(CounterACT) Research Centers of Excellence (U54).
    Date: March 16, 2017.
    Time: 8:30 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Pier 5 Hotel, 711 Eastern Avenue, Baltimore, MD 21202.
    Contact Person: Geoffrey G. Schofield, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4040-A, MSC 7850, Bethesda, MD 
20892, 301-435-1235, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Fellowship: Infectious Diseases and Microbiology.
    Date: March 16-17, 2017.
    Time: 9:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Alexander D. Politis, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3210, MSC 7808, Bethesda, MD 
20892, (301) 435-1150, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Small Business: Computational, Modeling, and Biodata 
Management.
    Date: March 16, 2017.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Allen Richon, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 6184, MSC 7892, Bethesda, MD 20892, 301-379-
9351, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR Panel: CounterACT-Countermeasurers against Chemical 
Threats.
    Date: March 17, 2017.
    Time: 8:30 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Pier 5 Hotel, 711 Eastern Avenue, Baltimore, MD 21202.
    Contact Person: Geoffrey G. Schofield, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4040-A, MSC 7850, Bethesda, MD 
20892, 301-435-1235, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Topics in Bacterial Pathogenesis and Host 
Interactions.
    Date: March 20, 2017.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892.
    Contact Person: Soheyla Saadi, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3211, MSC 7808, Bethesda, MD 20892, 301-435-
0903, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Fellowships: Oncology.
    Date: March 21-22, 2017.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Rd. NW., Washington, DC 20015.

[[Page 11235]]

    Contact Person: Reigh-Yi Lin, Ph.D., Scientific Review Officer, 
Center for Scientific Review, 6701 Rockledge Drive, Bethesda, MD 
20892, 301-827-6009, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR 16-366--Dual Purpose with Dual Benefit: Research in 
Biomedicine and Agriculture.
    Date: March 21, 2017.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Tera Bounds, DVM, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3214, MSC 7808, Bethesda, MD 
20892, 301-435-2306, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Fellowships: Risk, Prevention and Health Behavior Overflow.
    Date: March 21, 2017.
    Time: 9:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Stacey C. FitzSimmons, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3114, MSC 7808, Bethesda, MD 
20892, (301) 451-9956, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Urology and Urogynecology Small Business Applications.
    Date: March 21, 2017.
    Time: 9:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Ganesan Ramesh, Ph.D., Center for Scientific 
Review, National Institutes of Health, 6701 Rockledge Dr., Room 
2182, MSC 7818, Bethesda, MD 20892, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Topics in drug discovery and clinical field 
studies.
    Date: March 21, 2017.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Liangbiao Zheng, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3202, MSC 7808, Bethesda, MD 
20892, 301-996-5819, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: February 14, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-03281 Filed 2-17-17; 8:45 am]
BILLING CODE 4140-01-P

11234 Federal Register / Vol. 82, No. 33 / Tuesday, February 21, 2017 / Notices Agenda: To review and evaluate personal Place: National Institutes of Health, 6701 Name of Committee: Center for Scientific qualifications and performance, and Rockledge Drive, Bethesda, MD 20892. Review Special Emphasis Panel; Fellowship: competence of individual investigators. Contact Person: Peter J. Kozel, Ph.D., Infectious Diseases and Microbiology. Place: Residence Inn Bethesda, 7335 Scientific Review Officer, Center for Date: March 16–17, 2017. Wisconsin Avenue, Bethesda, MD 20814. Scientific Review, National Institutes of Time: 9:00 a.m. to 4:00 p.m. Contact Person: Alan P. Koretsky, Ph.D., Health, 6701 Rockledge Drive, Room 3139, Agenda: To review and evaluate grant Scientific Director, Division of Intramural Bethesda, MD 20892, 301–435–1116, kozelp@ applications. Research, National Institute of Neurological mail.nih.gov. Place: National Institutes of Health, 6701 Disorders and Stroke, NIH, 35 Convent Drive, Rockledge Drive, Bethesda, MD 20892 Room 6A 908, Bethesda, MD 20892, (301) Name of Committee: Center for Scientific (Virtual Meeting). 435–2232, koretskya@ninds.nih.gov. Review Special Emphasis Panel; Member Contact Person: Alexander D. Politis, Conflict: Psychopathology, Developmental (Catalogue of Federal Domestic Assistance Ph.D., Scientific Review Officer, Center for Disorders, Epigenetics, and Health. Scientific Review, National Institutes of Program Nos. 93.853, Clinical Research Date: March 14–15, 2017. Health, 6701 Rockledge Drive, Room 3210, Related to Neurological Disorders; 93.854, Time: 10:00 a.m. to 4:30 p.m. MSC 7808, Bethesda, MD 20892, (301) 435– Biological Basis Research in the Neurosciences, National Institutes of Health, Agenda: To review and evaluate grant 1150, politisa@csr.nih.gov. HHS). applications. Place: National Institutes of Health, 6701 Name of Committee: Center for Scientific Dated: February 14, 2017. Rockledge Drive, Bethesda, MD 20892 Review Special Emphasis Panel; Small Sylvia L. Neal, (Virtual Meeting). Business: Computational, Modeling, and Contact Person: Wind Cowles, Ph.D., Biodata Management. Program Analyst, Office of Federal Advisory Date: March 16, 2017. Committee Policy. Scientific Review Officer, Center for Time: 10:00 a.m. to 6:00 p.m. [FR Doc. 2017–03278 Filed 2–17–17; 8:45 am] Scientific Review, National Institutes of Agenda: To review and evaluate grant Health, 6701 Rockledge Drive, Room 3172, BILLING CODE 4140–01–P applications. Bethesda, MD 20892, cowleshw@csr.nih.gov. Place: National Institutes of Health, 6701 Name of Committee: Center for Scientific Rockledge Drive, Bethesda, MD 20892 DEPARTMENT OF HEALTH AND Review Special Emphasis Panel; Member (Virtual Meeting). Conflict: AIDS and Related Research. Contact Person: Allen Richon, Ph.D., HUMAN SERVICES Date: March 15, 2017. Scientific Review Officer, Center for Time: 11:00 a.m. to 3:00 p.m. Scientific Review, National Institutes of National Institutes of Health Agenda: To review and evaluate grant Health, 6701 Rockledge Drive, Room 6184, Center for Scientific Review; Notice of applications. MSC 7892, Bethesda, MD 20892, 301–379– Place: National Institutes of Health, 6701 9351, allen.richon@nih.hhs.gov. Closed Meetings Rockledge Drive, Bethesda, MD 20892 Name of Committee: Center for Scientific Pursuant to section 10(d) of the (Virtual Meeting). Review Special Emphasis Panel; PAR Panel: Federal Advisory Committee Act, as Contact Person: Dimitrios Nikolaos CounterACT-Countermeasurers against amended (5 U.S.C. App.), notice is Vatakis, Ph.D., Scientific Review Officer, Chemical Threats. Center for Scientific Review, National hereby given of the following meetings. Date: March 17, 2017. Institutes of Health, 6701 Rockledge Drive, Time: 8:30 a.m. to 6:00 p.m. The meetings will be closed to the Room 3190, Bethesda, MD 20892, 301–827– Agenda: To review and evaluate grant public in accordance with the 7480. provisions set forth in sections applications. Name of Committee: Center for Scientific Place: Pier 5 Hotel, 711 Eastern Avenue, 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Review Special Emphasis Panel; PAR Panel: Baltimore, MD 21202. as amended. The grant applications and Advanced Genomic Technology Contact Person: Geoffrey G. Schofield, the discussions could disclose Development. Ph.D., Scientific Review Officer, Center for confidential trade secrets or commercial Date: March 15, 2017. Scientific Review, National Institutes of property such as patentable material, Time: 11:00 a.m. to 6:00 p.m. Health, 6701 Rockledge Drive, Room 4040–A, and personal information concerning Agenda: To review and evaluate grant MSC 7850, Bethesda, MD 20892, 301–435– individuals associated with the grant applications. 1235, geoffreys@csr.nih.gov. applications, the disclosure of which Place: National Institutes of Health, 6701 Name of Committee: Center for Scientific would constitute a clearly unwarranted Rockledge Drive, Bethesda, MD 20892 Review Special Emphasis Panel; Member invasion of personal privacy. (Virtual Meeting). Conflict: Topics in Bacterial Pathogenesis Contact Person: Dominique Lorang-Leins, and Host Interactions. Name of Committee: Center for Scientific Ph.D., Scientific Review Officer, Center for Date: March 20, 2017. Review Special Emphasis Panel; Scientific Review, National Institutes of Time: 10:00 a.m. to 6:00 p.m. Fellowships: Genes, Genomes, and Genetics. Health, 6701 Rockledge Drive, Room 5108, Agenda: To review and evaluate grant Date: March 6–7, 2017. MSC 7766, Bethesda, MD 20892, Time: 8:00 a.m. to 5:00 p.m. applications. 301.326.9721, Lorangd@mail.nih.gov. Place: National Institutes of Health, 6701 Agenda: To review and evaluate grant applications. Name of Committee: Center for Scientific Rockledge Drive, Bethesda, MD 20892. Place: Marriott Chevy Chase, 5520 Review Special Emphasis Panel; PAR–16– Contact Person: Soheyla Saadi, Ph.D., Wisconsin Ave., Chevy Chase, MD 20815. 329: Countermeasures Against Chemical Scientific Review Officer, Center for Contact Person: Tatiana V. Cohen, Ph.D., Threats (CounterACT) Research Centers of Scientific Review, National Institutes of Scientific Review Officer, Center for Excellence (U54). Health, 6701 Rockledge Drive, Room 3211, Scientific Review, National Institutes of Date: March 16, 2017. MSC 7808, Bethesda, MD 20892, 301–435– Health, 6701 Rockledge Drive, Room 5213, Time: 8:30 a.m. to 6:00 p.m. 0903, saadisoh@csr.nih.gov. Bethesda, MD 20892, 301–455–2364, Agenda: To review and evaluate grant Name of Committee: Center for Scientific tatiana.cohen@nih.gov. applications. Review Special Emphasis Panel; sradovich on DSK3GMQ082PROD with NOTICES Name of Committee: Center for Scientific Place: Pier 5 Hotel, 711 Eastern Avenue, Fellowships: Oncology. Review Special Emphasis Panel; PAR–16– Baltimore, MD 21202. Date: March 21–22, 2017. 209: Investigator-Initiated Clinical Contact Person: Geoffrey G. Schofield, Time: 8:00 a.m. to 5:00 p.m. Sequencing Research. Ph.D., Scientific Review Officer, Center for Agenda: To review and evaluate grant Date: March 13, 2017. Scientific Review, National Institutes of applications. Time: 8:00 a.m. to 5:00 p.m. Health, 6701 Rockledge Drive, Room 4040–A, Place: Embassy Suites at the Chevy Chase Agenda: To review and evaluate grant MSC 7850, Bethesda, MD 20892, 301–435– Pavilion, 4300 Military Rd. NW., applications. 1235, geoffreys@csr.nih.gov. Washington, DC 20015. VerDate Sep<11>2014 17:15 Feb 17, 2017 Jkt 241001 PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 E:\FR\FM\21FEN1.SGM 21FEN1

Federal Register / Vol. 82, No. 33 / Tuesday, February 21, 2017 / Notices 11235 Contact Person: Reigh-Yi Lin, Ph.D., 93.846–93.878, 93.892, 93.893, National LPA1R activation bypasses the clinical Scientific Review Officer, Center for Institutes of Health, HHS) challenges resulting from the toxicity of Scientific Review, 6701 Rockledge Drive, Dated: February 14, 2017. substrate inhibitors of P-gp. This Bethesda, MD 20892, 301–827–6009, Natasha M. Copeland, invention describes the inhibition of lin.reigh-yi@nih.gov. Program Analyst, Office of Federal Advisory drug efflux by P-gp transport; thus, co- Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR 16– Committee Policy. administration of therapeutics with 366—Dual Purpose with Dual Benefit: [FR Doc. 2017–03281 Filed 2–17–17; 8:45 am] amitriptyline and other LPA1R Research in Biomedicine and Agriculture. BILLING CODE 4140–01–P activators provides a method for Date: March 21, 2017. increasing drug delivery to the CNS, and Time: 8:00 a.m. to 6:00 p.m. improving overall drug efficacy. Agenda: To review and evaluate grant DEPARTMENT OF HEALTH AND Moreover, drug delivery to other barrier applications. HUMAN SERVICES tissues will also be enhanced where a Place: Hyatt Regency Bethesda, One similar LPA1R–P-gp activity Bethesda Metro Center, 7400 Wisconsin National Institutes of Health Avenue, Bethesda, MD 20814. relationship exists. Contact Person: Tera Bounds, DVM, Ph.D., Potential Commercial Applications: Scientific Review Officer, Center for Government-Owned Inventions; • Drug Delivery to the CNS. Scientific Review, National Institutes of Availability for Licensing • Co-administration of therapeutics. Health, 6701 Rockledge Drive, Room 3214, • Blood-brain-barrier permeability. AGENCY: National Institutes of Health, Development Stage: MSC 7808, Bethesda, MD 20892, 301–435– HHS. 2306, boundst@csr.nih.gov. • Early stage. ACTION: Notice. Inventors: Ronald Cannon and David Name of Committee: Center for Scientific Review Special Emphasis Panel; Banks (NIEHS). SUMMARY: The inventions listed below Publications: Fellowships: Risk, Prevention and Health are owned by an agency of the U.S. Behavior Overflow. • Cannon et al., Neurosci Lett. 2017 Government. Feb 3;639:103–113 doi: 10.1016/ Date: March 21, 2017. Time: 9:00 a.m. to 1:00 p.m. FOR FURTHER INFORMATION CONTACT: j.neulet.2016.12.049. Agenda: To review and evaluate grant Licensing information may be obtained • Mesev, et al., Mol Pharmacol. 2017 applications. by emailing the indicated licensing Jan 24. pii: mol.116.107169. doi: Place: National Institutes of Health, 6701 contact at the National Heart, Lung, and 10.1124/mol.116.107169. Rockledge Drive, Bethesda, MD 20892 Blood, Office of Technology Transfer • More, et al., J Cereb Blood Flow (Telephone Conference Call). Metab. 2016 May 18. pii: Contact Person: Stacey C. FitzSimmons, and Development Office of Technology Transfer, 31 Center Drive, Room 4A29, 0271678X16650216. Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of MSC2479, Bethesda, MD 20892–2479; • Miller, et. al, Curr Pharm Des. Health, 6701 Rockledge Drive, Room 3114, telephone: 301–402–5579. A signed 2014;20(10):1463–71. Review. MSC 7808, Bethesda, MD 20892, (301) 451– Confidential Disclosure Agreement may • Cartwright, et al., J Cereb Blood 9956, fitzsimmonss@csr.nih.gov. be required to receive any unpublished Flow Metab. 2013 Mar;33(3):381–8. doi: Name of Committee: Center for Scientific information. 10.1038/jcbfm.2012.174. Review Special Emphasis Panel; Urology and Intellectual Property: HHS Reference SUPPLEMENTARY INFORMATION: The Urogynecology Small Business Applications. No. E–179–2065/0 and/1; U.S. following inventions are available for Date: March 21, 2017. Provisional Patent Applications 62/ licensing in accordance with 35 U.S.C. Time: 9:00 a.m. to 12:00 p.m. 332,888 filed May 6, 2016, and 62/ Agenda: To review and evaluate grant 209 and 37 CFR part 404 to achieve 453,718 filed February 2, 2017, applications. expeditious commercialization of respectively. Place: National Institutes of Health, 6701 results of federally-funded research and Licensing Contact: Michael Rockledge Drive, Bethesda, MD 20892 development. Technology description Shmilovich, Esq., CLP; 301–435–5019; (Telephone Conference Call). follows. shmilovm@mail.nih.gov. Contact Person: Ganesan Ramesh, Ph.D., Center for Scientific Review, National Methods for Improving Drug Delivery Dated: February 10, 2017. Institutes of Health, 6701 Rockledge Dr., to the Central Nervous System Michael Shmilovich, Room 2182, MSC 7818, Bethesda, MD 20892, The invention relates to the uses of Senior Licensing and Patenting Manager, ganesan.ramesh@nih.gov. the tricyclic antidepressant National Heart, Lung, and Blood Institute, Name of Committee: Center for Scientific amitriptyline, its bioactive metabolites, Office of Technology Transfer and Review Special Emphasis Panel; Member and other LPA1R activators to improve Development. Conflict: Topics in drug discovery and the bioavailability and delivery of [FR Doc. 2017–03306 Filed 2–17–17; 8:45 am] clinical field studies. Date: March 21, 2017. therapeutics to the central nervous BILLING CODE 4140–01–P Time: 10:00 a.m. to 5:00 p.m. system. This invention demonstrates Agenda: To review and evaluate grant that amitriptyline and other agents applications. selectively decrease P-glycoprotein (P- DEPARTMENT OF HEALTH AND Place: National Institutes of Health, 6701 gp) transport activity by ligand HUMAN SERVICES Rockledge Drive, Bethesda, MD 20892 activation of lysophosphatidic acid 1 (Virtual Meeting). receptor (LPA1R) at the blood-brain National Institutes of Health Contact Person: Liangbiao Zheng, Ph.D., barrier. P-gp is an effective target for Scientific Review Officer, Center for Eunice Kennedy Shriver National increasing drug delivery to the brain sradovich on DSK3GMQ082PROD with NOTICES Scientific Review, National Institutes of Institute of Child Health & Human Health, 6701 Rockledge Drive, Room 3202, (CNS) for two major reasons: (1) Its Development; Notice of Closed MSC 7808, Bethesda, MD 20892, 301–996– substrates include a large portion of on- Meetings 5819, zhengli@csr.nih.gov. the-market drugs, including (Catalogue of Federal Domestic Assistance chemotherapeutics, and (2) its Pursuant to section 10(d) of the Program Nos. 93.306, Comparative Medicine; directionality results in a net efflux of Federal Advisory Committee Act, as 93.333, Clinical Research, 93.306, 93.333, drugs from the brain. Additionally, amended (5 U.S.C. App.), notice is 93.337, 93.393–93.396, 93.837–93.844, specifically targeting P-gp through hereby given of the following meetings. VerDate Sep<11>2014 17:15 Feb 17, 2017 Jkt 241001 PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 E:\FR\FM\21FEN1.SGM 21FEN1


Document Created: 2018-02-01 15:04:44
Document Modified: 2018-02-01 15:04:44
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesMarch 6-7, 2017.
FR Citation82 FR 11234 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR